WASHINGTON, December 17, 2003 ( – Cathy Cleaver Ruse, Director of Planning and Information for the USCCB Secretariat for Pro-Life Activities, has warned against the misinformation being given women about the morning-after pill.  “It is being marketed and advertised as a contraceptive, but it works before and after conception.  Women deserve to know what is being marketed to them,” said Ruse.  Proponents of the proposal claim that the drug does not terminate a pregnancy because pregnancy is defined by some as beginning when the embryo implants in the uterine wall.  “This is an argument about rhetoric, not reality,” said Ruse.

  “There is a difference between preventing new human life and destroying life that has already begun,” Ruse noted.  “This drug company and its allies may argue that this distinction makes no difference, but to many women it is a very meaningful distinction,” said Ruse.  “Women are being misled about this drug, and putting it on the shelves of a drugstore would only exacerbate the problem.”

  Minor girls will have free access to Plan B without their parents’ knowledge if the proposal is approved.  “Parents deserve to know that if this proposal is approved, their teenaged daughters will have free access to a powerful abortion-inducing drug without their knowledge,” Ruse said.  “This is bad policy and bad medicine.”

  The USCCB comments against the FDA proposal may be read in their entirety at